Related Experiment Video
Updated: Jun 4, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Adverse blood transfusion outcomes: establishing causation
James P Isbister1, Aryeh Shander, Donat R Spahn
1Society for the Advancement of Blood Management, Department of Haematology, University of Sydney, Royal North Shore Hospital, St Leonards, New South Wales, Australia. james.isbister@sydney.edu.au
Allogeneic red blood cell (RBC) transfusions carry risks and unproven efficacy. Causation of adverse outcomes is often inferred from observational studies, necessitating a precautionary approach.
Area of Science:
- Transfusion Medicine
- Medical Statistics
- Clinical Causation
Background:
- Allogeneic red blood cell (RBC) transfusions are standard medical practice, based on assumptions of efficacy and safety.
- Growing evidence questions the efficacy and highlights risks of RBC transfusions in various clinical settings.
- Causation of transfusion-related adverse outcomes has not been definitively established through randomized clinical trials (RCTs).
Purpose of the Study:
- To critically analyze the evidence for causation of adverse clinical outcomes following RBC transfusions.
- To explore methodologies for establishing transfusion-related harm, particularly when RCTs are not feasible.
- To advocate for a precautionary approach to RBC transfusion due to accumulating risk data.
Main Methods:
- Examination of the nature and definition of causation in transfusion medicine.
- Application of deductive deterministic methods (e.g., modified Koch's postulates) for established transfusion hazards.
- Utilizing inferential probabilistic methodology (e.g., modified Bradford Hill criteria) for observational data linking RBC transfusions to adverse outcomes.
Main Results:
- While some transfusion hazards are well-established, causation for others, particularly immunomodulation and storage lesion effects, relies heavily on observational data.
- Modified Bradford Hill criteria can strengthen the case for RBC transfusion as a causal factor in adverse outcomes when RCTs are lacking.
- The evidence suggests RBC transfusions may be causal for adverse clinical outcomes in specific contexts.
Conclusions:
- A critical evaluation of existing evidence is needed to establish causation for RBC transfusion-related harms.
- Inferential probabilistic methods applied to observational studies are crucial for understanding transfusion risks.
- A greater precautionary principle should guide RBC transfusion practices, as RCTs may not always be feasible or ethically justifiable.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Errors occurring during blood pressure monitoring
Several factors...
Rh Blood Group
Blood Typing
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
